World's Best Scientists 2026 revealed!

Overview

Jee Woo Park is affiliated with Seoul National University in South Korea and has contributed extensively to the field of medicine, focusing particularly on hepatology and associated subfields. Their work spans a range of topics primarily related to liver diseases, oncology, and clinical treatment guidelines.

Their recent publications include:

  • Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma (2020, Journal of Hepatology)
  • EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma (2023, Journal of Hepatology)
  • Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial (2020, Journal of Hepatology)
  • APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (2021, Hepatology International)
  • Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line treatment for unresectable hepatocellular carcinoma (uHCC): First results from CheckMate 9DW (2024, Journal of Clinical Oncology)

Frequent co-authors collaborating with Jee Woo Park include:

  • Masatoshi Kudo
  • Bruno Sangro
  • Tae Hyun Kim
  • Bo Hyun Kim
  • Yuri Cho

The primary venues where Park publishes are:

  • Journal of Hepatology
  • Journal of Clinical Oncology
  • Clinical and Molecular Hepatology
  • Journal of Liver Cancer
  • Cancers

Their research predominantly falls within the broader field of medicine, with a strong focus on hepatology. Subfields of study connected to their work include:

  • Hepatology
  • Epidemiology
  • Oncology
  • Pulmonary and Respiratory Medicine
  • Surgery

Main topics researched by Jee Woo Park comprise:

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Liver Disease Diagnosis and Treatment
  • Hepatitis B Virus Studies
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Liver physiology and pathology
  • Renal cell carcinoma treatment
  • Cancer Immunotherapy and Biomarkers

Their work includes clinical guidelines and comparative studies on treatment modalities for liver cancers and related diseases, reflecting a research focus combining clinical practice with oncology and immunotherapy approaches. The collaborations and publication venues indicate active engagement in international scientific discourse on liver disease management and cancer treatment.

Best Publications

  • Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

    Masatoshi Kudo;Richard S. Finn;Shukui Qin;Kwang Hyub Han

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

    Adrian Ally;Miruna Balasundaram;Rebecca Carlsen;Eric Chuah

  • Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

    Ghassan K. Abou-Alfa;Tim Meyer;Ann Lii Cheng;Anthony B. El-Khoueiry

  • Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

    John Bridgewater;Peter R. Galle;Shahid A. Khan;Josep M. Llovet

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study

    Joong Won Park;Minshan Chen;Massimo Colombo;Lewis Rowland Roberts

  • Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial

    Ann Lii Cheng;Yoon Koo Kang;Deng Yn Lin;Joong Won Park

  • Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study

    Philip J. Johnson;Shukui Qin;Joong Won Park;Ronnie T.P. Poon

  • CheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)

    T. Yau;J.W. Park;R.S. Finn;A.-L. Cheng

  • Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study

    Josep M. Llovet;Thomas Decaens;Jean-Luc Raoul;Eveline Boucher

  • Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

    Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

    Franz X. Schaub;Varsha Dhankani;Ashton C. Berger;Mihir Trivedi

  • The role of hepatic resection in the treatment of hepatocellular cancer

    Sasan Roayaie;Ghalib Jibara;Parissa Tabrizian;Joong Won Park

  • Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

    Joshua D. Campbell;Joshua D. Campbell;Joshua D. Campbell;Christina Yau;Christina Yau;Reanne Bowlby;Yuexin Liu

  • A Prospective Evaluation of 18F-FDG and 11C-Acetate PET/CT for Detection of Primary and Metastatic Hepatocellular Carcinoma

    Joong-Won Park;Ji Hoon Kim;Seok Ki Kim;Keon Wook Kang

  • Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma

    Bruno Sangro;Ignacio Melero;Samir Wadhawan;Richard S Finn

  • 2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

    Joong Won Park;June Sung Lee;Kyung Suk Suh;Jin Wook Chung

  • Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients

    Ju Hyun Shim;Joong Won Park;Ji Hoon Kim;Min An

Frequent Co-Authors

R. A. Briere
R. A. Briere Carnegie Mellon University
Chuan Liu
Chuan Liu Sun Yat-sen University
Jürgen Becker
Jürgen Becker Karlsruhe Institute of Technology
Heng-Yun Ye
Heng-Yun Ye Jiangxi University of Science and Technology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

A medical career often goes beyond the role of a physician. Many students interested in medicine consider alternative or allied health professions, which can be accessed through flexible online pathways. These programs offer a faster and more affordable route for career changers or those seeking advancement in healthcare.

Earning credentials from pharmacy school online is an increasingly popular route, making advanced pharmacy degrees accessible even for those with busy schedules. For those interested in healthcare management and technology, online RHIT degree programs prepare graduates for vital roles in handling patient data and supporting hospital operations.

Administrative fields like medical billing and coding certification online can lead to strong job prospects, all without attending traditional, in-person classes. Additionally, becoming an advanced clinician is easier with options such as the most affordable nurse practitioner programs, combining flexibility with accredited training.

Online healthcare degrees offer a range of career paths in the medical field, allowing students to upskill and specialize in areas with high demand.

Best Scientists Citing Jee Woo Park

Trending Scientists

Recently Published Articles